RACIAL/ETHNIC DIFFERENCES IN USE OF ADJUVANT HORMONAL THERAPY AMONG WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER

被引:0
|
作者
Livaudais, J. [1 ]
Li, C. [1 ]
John, E. [1 ]
Daly, M. [1 ]
Terry, M. [1 ]
Buys, S. [1 ]
Thompson, B. [1 ]
LaCroix, A. [1 ]
Habel, L. [1 ]
Coronado, G. [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:S23 / S23
页数:1
相关论文
共 50 条
  • [1] Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
    Jennifer C. Livaudais
    Dawn L. Hershman
    Laurel Habel
    Lawrence Kushi
    Scarlett Lin Gomez
    Christopher I. Li
    Alfred I. Neugut
    Louis Fehrenbacher
    Beti Thompson
    Gloria D. Coronado
    Breast Cancer Research and Treatment, 2012, 131 : 607 - 617
  • [2] Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
    Livaudais, Jennifer C.
    Hershman, Dawn L.
    Habel, Laurel
    Kushi, Lawrence
    Gomez, Scarlett Lin
    Li, Christopher I.
    Neugut, Alfred I.
    Fehrenbacher, Louis
    Thompson, Beti
    Coronado, Gloria D.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (02) : 607 - 617
  • [3] THE USE OF ADJUVANT ENDOCRINE THERAPY IN OLDER WOMEN WITH ESTROGEN RECEPTOR-POSITIVE (ER plus ) BREAST CANCER (BC)
    Aapro, M.
    Crivellari, D.
    ANNALS OF ONCOLOGY, 2008, 19 : 208 - 209
  • [4] Racial/ethnic difference in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer
    Farias, Albert
    Du, Xianglin L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [5] Weakly hormone receptor-positive breast cancer and use of adjuvant hormonal therapy
    Lin, Cassandra M.
    Jaswal, Jasbir
    Vandenberg, Theodore
    Tuck, Alan
    Brackstone, Muriel
    CURRENT ONCOLOGY, 2013, 20 (06) : E612 - E613
  • [6] Racial/Ethnic Differences in Use and Duration of Adjuvant Hormonal Therapy for Breast Cancer in the Women's Health Initiative
    Livaudais, Jennifer C.
    LaCroix, Andrea
    Chlebowski, Rowan T.
    Li, Christopher I.
    Habel, Laurel A.
    Simon, Michael S.
    Thompson, Beti
    Erwin, Deborah O.
    Hubbell, F. Allan
    Coronado, Gloria D.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (03) : 365 - 373
  • [7] Racial and Ethnic Differences in Adjuvant Hormonal Therapy Use
    Livaudais, Jennifer C.
    Li, Christopher
    John, Esther M.
    Terry, Mary Beth
    Daly, Mary
    Buys, Saundra S.
    Habel, Laurel
    Thompson, Beti
    Yanez, N. David
    Coronado, Gloria D.
    JOURNAL OF WOMENS HEALTH, 2012, 21 (09) : 950 - 958
  • [8] Suboptimal adherence to adjuvant endocrine therapy (ET) in Brazilian women with early-stage estrogen receptor-positive (ER plus ) breast cancer
    Assad-Suzuki, Daniele
    Resende, Heloisa
    Santos, Danielle
    Moura, Fernanda
    Oliveira, Sulene
    Shimada, Andrea
    Galvao, Anna Luiza
    Souza, Bruno
    Castro, Amanda
    Andrade, Monalisa
    Beckedorff, Yuri
    Magalhaes, Maria Cristina
    Souza, Cristiano
    Paiva, Carlos
    Pereira, Daniela
    Rodrigues, Angelica
    Rosa, Daniela
    Barroso-Sousa, Romualdo
    CANCER RESEARCH, 2024, 84 (09)
  • [9] Racial/ethnic differences in 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer
    Gill, Jasmin
    Yendamuri, Keerti
    Chatterjee, Udit
    Yao, Song
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    Ma, Sung Jun
    BMC CANCER, 2024, 24 (01)
  • [10] Trade-off preferences regarding adjuvant endocrine therapy among women with estrogen receptor-positive breast cancer
    Wouters, H.
    Maatman, G. A.
    Van Dijk, L.
    Bouvy, M. L.
    Vree, R.
    Van Geffen, E. C. G.
    Nortier, J. W.
    Stiggelbout, A. M.
    ANNALS OF ONCOLOGY, 2013, 24 (09) : 2324 - 2329